188 related articles for article (PubMed ID: 29717026)
21. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
22. AEG-1 associates with metastasis in papillary thyroid cancer through upregulation of MMP2/9.
Huang LL; Wang Z; Cao CJ; Ke ZF; Wang F; Wang R; Luo CQ; Lu X; Wang LT
Int J Oncol; 2017 Sep; 51(3):812-822. PubMed ID: 28731152
[TBL] [Abstract][Full Text] [Related]
23. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
24. PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms.
Nicolussi A; D'Inzeo S; Mincione G; Buffone A; Di Marcantonio MC; Cotellese R; Cichella A; Capalbo C; Di Gioia C; Nardi F; Giannini G; Coppa A
Int J Oncol; 2014 Feb; 44(2):548-56. PubMed ID: 24316730
[TBL] [Abstract][Full Text] [Related]
25. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
26. The CXCL12-CXCR4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling.
Lin Y; Ma Q; Li L; Wang H
Biochem Cell Biol; 2018 Oct; 96(5):619-626. PubMed ID: 29316404
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
[TBL] [Abstract][Full Text] [Related]
28. Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer.
Garcia-Rendueles AR; Rodrigues JS; Garcia-Rendueles ME; Suarez-Fariña M; Perez-Romero S; Barreiro F; Bernabeu I; Rodriguez-Garcia J; Fugazzola L; Sakai T; Liu F; Cameselle-Teijeiro J; Bravo SB; Alvarez CV
Oncogene; 2017 Feb; 36(5):652-666. PubMed ID: 27452523
[TBL] [Abstract][Full Text] [Related]
29. Sam68/KHDRBS1 is critical for colon tumorigenesis by regulating genotoxic stress-induced NF-κB activation.
Fu K; Sun X; Wier EM; Hodgson A; Liu Y; Sears CL; Wan F
Elife; 2016 Jul; 5():. PubMed ID: 27458801
[TBL] [Abstract][Full Text] [Related]
30. The role of ELK3 to regulate peritumoral lymphangiogenesis and VEGF-C production in triple negative breast cancer cells.
Oh N; Park JI; Park JH; Kim KS; Lee DR; Park KS
Biochem Biophys Res Commun; 2017 Mar; 484(4):896-902. PubMed ID: 28188790
[TBL] [Abstract][Full Text] [Related]
31. Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells.
Baldan F; Mio C; Allegri L; Conzatti K; Toffoletto B; Puppin C; Radovic S; Vascotto C; Russo D; Di Loreto C; Damante G
Oncotarget; 2016 Sep; 7(39):63388-63407. PubMed ID: 27542231
[TBL] [Abstract][Full Text] [Related]
32. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1).
Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A
J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400
[TBL] [Abstract][Full Text] [Related]
33. The expression and role of serum response factor in papillary carcinoma of the thyroid.
Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF/MEK/ERK signaling pathway.
Wang Y; Lin X; Fu X; Yan W; Lin F; Kuang P; Luo Y; Lin E; Hong X; Wu G
Oncol Rep; 2018 Aug; 40(2):859-866. PubMed ID: 29917164
[TBL] [Abstract][Full Text] [Related]
35. The steroid receptor coactivator-3 is a tumor promoter in a mouse model of thyroid cancer.
Ying H; Willingham MC; Cheng SY
Oncogene; 2008 Jan; 27(6):823-30. PubMed ID: 17653082
[TBL] [Abstract][Full Text] [Related]
36. DNA methylation signatures identify biologically distinct thyroid cancer subtypes.
Rodríguez-Rodero S; Fernández AF; Fernández-Morera JL; Castro-Santos P; Bayon GF; Ferrero C; Urdinguio RG; Gonzalez-Marquez R; Suarez C; Fernández-Vega I; Fresno Forcelledo MF; Martínez-Camblor P; Mancikova V; Castelblanco E; Perez M; Marrón PI; Mendiola M; Hardisson D; Santisteban P; Riesco-Eizaguirre G; Matías-Guiu X; Carnero A; Robledo M; Delgado-Álvarez E; Menéndez-Torre E; Fraga MF
J Clin Endocrinol Metab; 2013 Jul; 98(7):2811-21. PubMed ID: 23666970
[TBL] [Abstract][Full Text] [Related]
37. [STAT3 and NF-κB is activated in papillary thyroid carcinoma tissues].
Wang F; Luo D; Liu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1386-1389. PubMed ID: 27667468
[TBL] [Abstract][Full Text] [Related]
38. Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors.
Hung CJ; Ginzinger DG; Zarnegar R; Kanauchi H; Wong MG; Kebebew E; Clark OH; Duh QY
J Clin Endocrinol Metab; 2003 Aug; 88(8):3694-9. PubMed ID: 12915657
[TBL] [Abstract][Full Text] [Related]
39. BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy.
Bommarito A; Richiusa P; Carissimi E; Pizzolanti G; Rodolico V; Zito G; Criscimanna A; Di Blasi F; Pitrone M; Zerilli M; Amato MC; Spinelli G; Carina V; Modica G; Latteri MA; Galluzzo A; Giordano C
Endocr Relat Cancer; 2011 Dec; 18(6):669-85. PubMed ID: 21903858
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of endocrine gland-derived vascular endothelial growth factor in papillary thyroid cancers displaying infiltrative patterns, lymph node metastases, and BRAF mutation.
Pasquali D; Santoro A; Bufo P; Conzo G; Deery WJ; Renzullo A; Accardo G; Sacco V; Bellastella A; Pannone G
Thyroid; 2011 Apr; 21(4):391-9. PubMed ID: 21385081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]